Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000880 · ClinicalTrials.gov registry record · NA
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
A NA study of Breast Cancer and Prostate Cancer, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 603
- Enrollment target
- 2
- Study locations
NCT04000880: Active NA study of Breast Cancer and Prostate Cancer, sponsored by University of Alabama at Birmingham.
NCT04000880 is a NA study of Breast Cancer and Prostate Cancer that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 603 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04000880, a NA study of Breast Cancer and Prostate Cancer, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 603 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study will test the efficacy of interactive, web-based interventions that improve diet, physical activity and weight management changes among early stage survivors of breast, prostate, colorectal, endometrial, renal, thyroid, and ovarian cancers, as well as multiple myeloma and non-Hodgkin Lymphoma. Overarching outcomes also include physical function and performance, muscle mass, quality of life, and health utilities.
Primary Outcome
Participants completed two dietary recalls (one weekday and one weekend day) via telephone using a multipass method and the Nutrition Data Systems for Research (NDSR) software. The software averages the 2-day resulting data and calculates the Healthy Eating Index (HEI)-2015. The HEI indicates how closely someone's diet follows the Dietary Guidelines for Americans. The index range is 0 to 100 with an index closer to 100 indicating a healthier, well-balanced diet.
Conditions Studied
Interventions
- BEHAVIORAL Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
- OTHER Diet-Exercise
- OTHER Exercise-Diet
- OTHER Combined Diet and Exercise
Study Locations (2)
Alabama
- University of Alabama at Birmingham - Birmingham
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 603 participants |
| Start Date | 2020-03-04 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
What the registry record for NCT04000880 still lists
NCT04000880 is an interventional study that assigns participants to a tested intervention. The registered 603 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (78% lower).
The record links to 9 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health is the first listed.
NCT04000880 reports a single indexed study location in Alabama, Tennessee.
Frequently Asked Questions
What is clinical trial NCT04000880 about?
NCT04000880 is a clinical study titled "Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health". This research study will test the efficacy of interactive, web-based interventions that improve diet, physical activity and weight management changes among early stage survivors of breast, prostate, colorectal, endometrial, renal, thyroid, and ovarian cancers, as well as multiple myeloma and non-Hod...
What is the current status of trial NCT04000880?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 603 participants. The study started on 2020-03-04. Estimated completion is 2025-09-01.
What conditions does trial NCT04000880 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Multiple Myeloma, Colorectal Cancer, Endometrial Cancer.
What interventions are being tested in trial NCT04000880?
The interventions under investigation include: Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health (BEHAVIORAL), Diet-Exercise (OTHER), Exercise-Diet (OTHER), Combined Diet and Exercise (OTHER).
Who is sponsoring clinical trial NCT04000880?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04000880 being conducted?
This trial has 2 study locations across Alabama, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04000880's enrollment target sits among peer trials
603 175th of 1224 higher than 1,050 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI